JMN Financial’s GSK GSK Stock Holding History

JMN Financial’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$407K	Buy	7,697 +409	+6%	+$21.6K	0.32%	88
2026 Q1	$406K	Buy	7,288 +195	+3%	+$10.6K	0.4%	71
2025 Q4	$351K	Buy	+7,093	New	+$331K	0.35%	85

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JMN Financial's GSK Position: Q2 2026 in Review

JMN Financial increased its GSK (GSK) stake by 5.6% in Q2 2026, buying an estimated $21.6K and bringing the position to 7,697 shares worth $407K. The position accounts for 0.32% of the portfolio, ranked #88.

JMN Financial first reported a position in GSK in Q4 2025 and has held it in 3 quarters since. 999 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

JMN Financial held 7,697 shares of GSK worth $407K as of Q2 2026.
JMN Financial bought 409 GSK shares in Q2 2026, an estimated $21.6K.
GSK made up 0.32% of JMN Financial's portfolio in Q2 2026, its #88 holding.
JMN Financial first reported a position in GSK in Q4 2025 and has held it in 3 quarters since.
999 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on JMN Financial's 13F filing for Q2 2026, filed 10 Aug 2026.